Russell Investments Group
LEGN icon

Russell Investments Group’s Legend Biotech LEGN Stock Holding History

Russell Investments Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
11,762
-181,760
-94% -$4.9M ﹤0.01% 2963
2026
Q1 		$3.35M Buy
193,522
+17,689
+10% +$337K ﹤0.01% 1579
2025
Q4 		$3.79M Buy
175,833
+174,806
+17,021% +$5.01M ﹤0.01% 1489
2025
Q3 		$33.5K Hold
1,027
– – ﹤0.01% 3428
2025
Q2 		$36.4K Buy
1,027
+13
+1% +$421 ﹤0.01% 3054
2025
Q1 		$34.4K Sell
1,014
-243,839
-100% -$8.74M ﹤0.01% 2989
2024
Q4 		$7.97M Sell
244,853
-30,632
-11% -$1.27M 0.01% 926
2024
Q3 		$13.4M Buy
275,485
+91,071
+49% +$4.85M 0.02% 720
2024
Q2 		$8.17M Buy
184,414
+673
+0.4% +$31K 0.01% 916
2024
Q1 		$10.3M Buy
183,741
+83,150
+83% +$5.01M 0.02% 819
2023
Q4 		$6.05M Sell
100,591
-9,473
-9% -$600K 0.01% 1038
2023
Q3 		$7.39M Buy
110,064
+25,865
+31% +$1.8M 0.01% 891
2023
Q2 		$5.81M Buy
84,199
+31,680
+60% +$2.07M 0.01% 1028
2023
Q1 		$2.53M Sell
52,519
-2,653
-5% -$130K 0.01% 1436
2022
Q4 		$2.75M Buy
55,172
+18,118
+49% +$878K 0.01% 1391
2022
Q3 		$1.51M Buy
37,054
+10,924
+42% +$513K ﹤0.01% 1713
2022
Q2 		$1.44M Buy
26,130
+5,896
+29% +$249K ﹤0.01% 1766
2022
Q1 		$735K Buy
+20,234
New +$799K ﹤0.01% 2103
2020
Q3 		– Sell
-1,600
Closed -$65K – 3224
2020
Q2 		$65K Buy
+1,600
New +$62.5K ﹤0.01% 2955

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Russell Investments Group's LEGN Position: Q2 2026 in Review

Russell Investments Group reduced its Legend Biotech (LEGN) stake by 94% in Q2 2026, selling an estimated $4.9M and leaving 11,762 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Russell Investments Group first reported a position in LEGN in Q2 2020 and has held it in 19 quarters since. The position peaked at $13.4M in Q3 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Russell Investments Group held 11,762 shares of Legend Biotech worth $340K as of Q2 2026.
  • Russell Investments Group sold 181,760 Legend Biotech shares in Q2 2026, an estimated $4.9M.
  • Legend Biotech made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2963 holding.
  • Russell Investments Group first reported a position in Legend Biotech in Q2 2020 and has held it in 19 quarters since.
  • Russell Investments Group's Legend Biotech position peaked at $13.4M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.